Technical Analysis for NARI - Inari Medical, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 20 DMA | Bearish | 1.39% | |
| Multiple of Ten Bearish | Other | 1.39% | |
| Inside Day | Range Contraction | -2.53% | |
| Gapped Down | Weakness | -2.53% | |
| MACD Bearish Signal Line Cross | Bearish | -3.20% | |
| Multiple of Ten Bullish | Other | -3.20% | |
| Multiple of Ten Bullish | Other | -1.74% | |
| Outside Day | Range Expansion | -1.74% | |
| Multiple of Ten Bearish | Other | 0.89% | |
| Overbought Stochastic | Strength | 0.89% |
| Alert | Time |
|---|---|
| 20 DMA Resistance | about 1 hour ago |
| Up 2% | about 2 hours ago |
| Rose Above 20 DMA | about 2 hours ago |
| 60 Minute Opening Range Breakout | about 2 hours ago |
| Up 1% | about 3 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 10/30/2024
Inari Medical, Inc. Description
Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari is focused on treating venous thromboembolism and improving the quality of life of patients suffering from this disease by safely and effectively removing blood clots. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The ClotTriever system is 510(k)-cleared by the FDA for thrombectomy in the peripheral vessels and is used to treat patients suffering from deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA for the treatment of pulmonary embolism.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Disease FDA Catheter Hematology Quality Of Life Veins Thrombosis Angiology Blood Clots Deep Vein Thrombosis Embolectomy Pulmonary Embolism Thrombectomy Thrombus Venous Diseases Venous Thrombosis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 67.13 |
| 52 Week Low | 36.73 |
| Average Volume | 878,269 |
| 200-Day Moving Average | 46.80 |
| 50-Day Moving Average | 45.53 |
| 20-Day Moving Average | 49.28 |
| 10-Day Moving Average | 50.97 |
| Average True Range | 2.24 |
| RSI (14) | 51.69 |
| ADX | 31.91 |
| +DI | 23.38 |
| -DI | 18.16 |
| Chandelier Exit (Long, 3 ATRs) | 46.96 |
| Chandelier Exit (Short, 3 ATRs) | 49.14 |
| Upper Bollinger Bands | 55.11 |
| Lower Bollinger Band | 43.46 |
| Percent B (%b) | 0.48 |
| BandWidth | 23.64 |
| MACD Line | 1.55 |
| MACD Signal Line | 1.80 |
| MACD Histogram | -0.2474 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 53.76 | ||||
| Resistance 3 (R3) | 53.94 | 52.53 | 52.96 | ||
| Resistance 2 (R2) | 52.53 | 51.32 | 52.44 | 52.70 | |
| Resistance 1 (R1) | 50.77 | 50.57 | 50.07 | 50.59 | 52.43 |
| Pivot Point | 49.36 | 49.36 | 49.01 | 49.27 | 49.36 |
| Support 1 (S1) | 47.60 | 48.15 | 46.90 | 47.42 | 45.57 |
| Support 2 (S2) | 46.19 | 47.40 | 46.10 | 45.30 | |
| Support 3 (S3) | 44.43 | 46.19 | 45.04 | ||
| Support 4 (S4) | 44.25 |
